Skip to content

Dr Van der Biest A-M

Active Private limited companyfounded 2023active for 3 yearsHazestraat 85, 9620 ZottegemKBO/BCE: BE 0800.055.901

Lifetime

3 annual accounts with figures on one time axis
peak of €105,511 in 2023
€51,504▲ 25.5%
peak of €82,601 in 2023
€39,605▲ 27.0%
peak of €155,898 in 2025
€155,898▲ 34.1%
€9,419▼ 56.5%
Board1 name since 2023
1 director
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Gross margin from €41,044 to €51,504Result from €31,193 to €39,605Equity from €116,294 to €155,898Debts from €21,677 to €9,419

Key points

from the 2025 annual accounts

Equity

€155,898 ▲ 34.1%

Dr Van der Biest A-M has made a profit in every financial year since 2023.

Turnover

≈ €110,000 estimated

The micro format states no turnover.

Liquidity

17.55 was 6.36 in 2024

Short-term debts fell from €21,677 to €9,419.

Filings

3 annual accounts 1 late
AprilJune31 JulyOctober202320242025

The 2023 accounts came 21 days late. The other two were filed on time.

Position in the sector

94.3%

Higher solvency than 90% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as Dr Van der Biest A-M has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for Dr Van der Biest A-M. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 30-03-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0800055901
Incorporation Founding capital of €2,500, 100 shares · Founded by · appointed as director · published on 30-03-2023 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
Dr Van der Biest A-M Zottegem €165,318 €51,504 94.3% -
Mithridate Genk €164,214 €51,892 -191.7% -
THIBAULT WARLOP" Tournai €152,366 €50,692 91.7% -
TROCARDIO Seraing €165,713 €46,112 18.7% -
Dokter Pillen Sara Merelbeke-Melle €124,313 €52,706 57.0% 0
Dr. Gwendolyne Peeters - anesthesie-reanimatie Merelbeke-Melle €147,076 €65,760 96.1% -
IRIS LEBBE Merelbeke-Melle €221,908 €47,635 13.8% -

These companies have the same main activity as Dr Van der Biest A-M: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €124,000 and €222,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 28-03-2023Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.346.373.7789600 Ronse, since 28-03-2023
Financial year end
31 December
Peppol
Reachable since 19-04-2025
Company details

Annual accounts 2025

€165,318▲ 19.8%
Filing
Filed on 26-06-2026, 35 days before the end of the filing period
Financials

Insights on Dr Van der Biest A-M

Dr Van der Biest A-M files the micro format. That format states no turnover. The gross margin fell from €105,511 in 2023 to €51,504 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr Van der Biest A-M

What is the company number of Dr Van der Biest A-M?
The company number of Dr Van der Biest A-M is 0800.055.901. The VAT number is the same number with BE in front: BE 0800.055.901.
Where is Dr Van der Biest A-M based?
The registered office is at Hazestraat 85, 9620 Zottegem.Company details
What does Dr Van der Biest A-M do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr Van der Biest A-M?
Dr Van der Biest A-M is a private limited company (BV).
When was Dr Van der Biest A-M founded?
Dr Van der Biest A-M was founded on 28-03-2023.
Is Dr Van der Biest A-M still active?
Yes, Dr Van der Biest A-M is an active enterprise in the KBO register.
What is the turnover of Dr Van der Biest A-M?
The turnover in financial year 2025 is about €110,000. This figure is estimated from the gross margin of €51,504 and 33 comparable companies (NACE 862). It probably lies between €87,000 and €140,000.Financials
Is Dr Van der Biest A-M profitable?
In financial year 2025, Dr Van der Biest A-M made a profit of €39,605.
Where can I find the annual accounts of Dr Van der Biest A-M?
Dr Van der Biest A-M filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr Van der Biest A-M due?
Dr Van der Biest A-M must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.